Literature DB >> 30893436

Future Antibacterial Strategies: From Basic Concepts to Clinical Challenges.

Vincent Cattoir1,2,3, Brice Felden1.   

Abstract

This review presents potential benefits and limitations of innovative strategies that are currently investigated for the discovery of novel antibacterial agents to prevent or treat infections caused by multidrug-resistant organisms.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antibacterials; antimicrobial resistance; multidrug resistance; therapeutic alternatives

Mesh:

Substances:

Year:  2019        PMID: 30893436     DOI: 10.1093/infdis/jiz134

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Emerging Prospects of Nanozymes for Antibacterial and Anticancer Applications.

Authors:  Nayanika Chakraborty; Sona Gandhi; Rajni Verma; Indrajit Roy
Journal:  Biomedicines       Date:  2022-06-10

2.  Phage lysin that specifically eliminates Clostridium botulinum Group I cells.

Authors:  Zhen Zhang; Meeri Lahti; François P Douillard; Hannu Korkeala; Miia Lindström
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

3.  Computational and biological studies of novel thiazolyl coumarin derivatives synthesized through Suzuki coupling.

Authors:  Shaista Parveen; Saima Kalsoom; Rifhat Bibi; Ambreen Asghar; Abdul Hameed; Waqar Ahmed; Abbas Hassan
Journal:  Turk J Chem       Date:  2020-12-16       Impact factor: 1.239

4.  The Use of Translational Modelling and Simulation to Develop Immunomodulatory Therapy as an Adjunct to Antibiotic Treatment in the Context of Pneumonia.

Authors:  Robin Michelet; Moreno Ursino; Sandrine Boulet; Sebastian Franck; Fiordiligie Casilag; Mara Baldry; Jens Rolff; Madelé van Dyk; Sebastian G Wicha; Jean-Claude Sirard; Emmanuelle Comets; Sarah Zohar; Charlotte Kloft
Journal:  Pharmaceutics       Date:  2021-04-22       Impact factor: 6.321

Review 5.  Nanomaterials as Delivery Vehicles and Components of New Strategies to Combat Bacterial Infections: Advantages and Limitations.

Authors:  Atanu Naskar; Kwang-Sun Kim
Journal:  Microorganisms       Date:  2019-09-16

Review 6.  Antibiotics in the clinical pipeline in October 2019.

Authors:  Mark S Butler; David L Paterson
Journal:  J Antibiot (Tokyo)       Date:  2020-03-10       Impact factor: 2.649

Review 7.  Two-dimensional nanomaterials beyond graphene for antibacterial applications: current progress and future perspectives.

Authors:  Linqiang Mei; Shuang Zhu; Wenyan Yin; Chunying Chen; Guangjun Nie; Zhanjun Gu; Yuliang Zhao
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

8.  Linearized esculentin-2EM shows pH dependent antibacterial activity with an alkaline optimum.

Authors:  Erum Malik; David A Phoenix; Timothy J Snape; Frederick Harris; Jaipaul Singh; Leslie H G Morton; Sarah R Dennison
Journal:  Mol Cell Biochem       Date:  2021-06-06       Impact factor: 3.396

Review 9.  Pharmacological Activity of Garcinia indica (Kokum): An Updated Review.

Authors:  Sung Ho Lim; Ho Seon Lee; Chang Hoon Lee; Chang-Ik Choi
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-20

10.  Antibacterial peptides inhibit MC3T3-E1 cells apoptosis induced by TNF-α through p38 MAPK pathway.

Authors:  Rong-Jian Lu; He-Lin Xing; Chao-Jun Liu; Yao Shu; Biao Guo; Xiao-Yang Chu; Chun-Fang Wang; Lin Feng; Kai-Tao Yu
Journal:  Ann Transl Med       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.